Skip to content

Discontinued — last reported Q1 '22

D&A at other companies

Novanta logo
NovantaNOVT
$5.77M+4.0%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$67.15M-44.2%
FactSet Research Systems logo
FactSet Research SystemsFDS
BWX Technologies logo
BWX TechnologiesBWXT
SPX Technologies logo
SPX TechnologiesSPXC
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Segments

By segment

See full
Nuclear & Safety$24.3M+42.9%
Medical Segment$16.2M-1.2%

Other financials

Income statement

See full
Revenue$257.6M+27.5%
Gross profit$119.1M+23.9%
Operating income$3.7M-57.5%
Net income-$3.4M-1,233%
EPS (diluted)-$0.01

Balance sheet

See full
Cash & equivalents$400.8M+115%
Total debt$478.3M-33.5%
Total equity$1.8B+22.2%
Total assets$3.5B+34.7%

Cash flow

See full
Operating cash flow$18.9M-46.9%
CapEx$9.5M+11.8%
Free cash flow$9.4M-65.3%

Valuation

See full
Market cap$4.55B+35.0%

Profitability

See full
Gross margin47.1%+0.1pp
Operating margin4.7%+0.3pp
Net margin2.6%
FCF margin9.1%-0.6pp

Returns & leverage

See full
Return on equity1.5%
Debt / equity0.3×-0.2×
Current ratio3.2×+1.0×

Where this comes from

Reported directly by Mirion Technologies in its filing.

Tagged under the XBRL concept us-gaap:DepreciationAndAmortization.

The official record: Mirion Technologies’s 10-Q, filed May 5, 2022, on SEC EDGAR. View the filing →

Ask your AI about Mirion Technologies's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mirion Technologies's D&A?
Mirion Technologies (MIR) reported D&A of $44.9M in Q1 2022.
What does D&A mean?
Non-cash expense representing the systematic allocation of tangible asset costs (depreciation) and intangible asset costs (amortization) over their useful lives.